| abstract |
Treating a inflammatory neurodegenerative disease or at least one symptom thereof in a subject by administering a therapeutic composition comprising at least one electrokinetic altered fluid (eg, a galvanically produced oxygen enriched fluid) of the present invention A method is provided. Certain embodiments provide methods for inhibiting and / or regulating the function and / or activity of effector T cells and / or for cell based immunotolerant treatment. In certain embodiments, such methods include ex vivo exposure of T cells and / or APCs to at least one electrokinetically altered fluid disclosed herein. Combination treatment is further provided. |